SOURCE: annual_report_text (1).txt
CHUNK: 193 of 1106
SIZE: 518 characters
PREVIOUS: chunk_0192_annual_report_text (1).txt
NEXT: chunk_0194_annual_report_text (1).txt
------------------------------
=== Page 52 ===
IBA Annual Report 2023 
49. IBA 
continued in overheads and R&D to drive the 
future growth of the business, alongside 
inflationary 
pressures 
and 
some 
foreign 
exchange impacts. There are 33 PT projects under construction or 
installation. This consists of nine ProteusPLUS 
and 24 ProteusONE systems. IBA is the 
market leader in proton therapy with a 42% 
market share, and there continues to be an 
active pipeline of potential projects, with 
particular interest coming from Asia and the 
USA.